Document:

<PAGE>

                                                                  EXECUTION COPY

                                                                     EXHIBIT 4.4

================================================================================

                          REGISTRATION RIGHTS AGREEMENT

                            Dated as of June 22, 2004

                                  by and among

                              IASIS HEALTHCARE LLC
                            IASIS CAPITAL CORPORATION

                        The Guarantors Signatories Hereto

                                       and

                         BANC OF AMERICA SECURITIES LLC
                          CITIGROUP GLOBAL MARKETS INC.
                              GOLDMAN, SACHS & CO.
                              LEHMAN BROTHERS INC.
               MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED
                          WACHOVIA CAPITAL MARKETS, LLC

================================================================================
<PAGE>

      This Registration Rights Agreement (this "Agreement") is made and entered
into as of June 22, 2003, by and among IASIS Healthcare LLC, a Delaware limited
liability company, and IASIS Capital Corporation, a Delaware corporation
(together, the "Company"), the subsidiaries of the Company listed on the
signature pages hereof (the "Guarantors") and Banc of America Securities LLC,
Citigroup Global Markets Inc., Goldman, Sachs & Co., Lehman Brothers Inc.,
Merrill Lynch, Pierce, Fenner & Smith Incorporated and Wachovia Capital Markets,
LLC (collectively, the "Initial Purchasers"), who have agreed to purchase the
Company's 8-3/4% Senior Subordinated Notes due 2014 (the "Initial Notes")
pursuant to the Purchase Agreement (as defined below).

      This Agreement is made pursuant to the Purchase Agreement, dated June 10,
2004 (the "Purchase Agreement"), by and among the Company, IASIS Healthcare
Corporation, the Guarantors and the Initial Purchasers. In order to induce the
Initial Purchasers to purchase the Initial Notes, the Company and the Guarantors
have agreed to provide the registration rights set forth in this Agreement. The
execution and delivery of this Agreement is a condition to the obligations of
the Initial Purchasers set forth in Section 7 of the Purchase Agreement.
Capitalized terms used herein and not otherwise defined shall have the meaning
assigned to them in the Indenture, dated as of the date hereof, by and among the
Company, the Guarantors and The Bank of New York Trust Company, N.A., as Trustee
(the "Trustee"), relating to the Initial Notes and the Exchange Notes (as
defined below) (the "Indenture").

      The parties hereby agree as follows:

SECTION 1. DEFINITIONS

      As used in this Agreement, the following capitalized terms shall have the
following meanings:

      Act: The Securities Act of 1933, as amended.

      Affiliate: As defined in Rule 144.

      Broker-Dealer: Any broker or dealer registered under the Exchange Act.

      Business Day: Any day except a Saturday, Sunday or other day in the City
of New York on which banks are authorized or ordered to close.

      Closing Date: The date hereof.

      Commission: The Securities and Exchange Commission.

      Consummate: An Exchange Offer shall be deemed "Consummated" for purposes
of this Agreement upon the occurrence of (a) the filing and effectiveness under
the Act of the Exchange Offer Registration Statement relating to the Exchange
Notes to be issued in the Exchange Offer, (b) the maintenance of such Exchange
Offer Registration Statement continuously effective and the keeping of such
Exchange Offer open for a period not less than the minimum period required
pursuant to Section 3(b) hereof and (c) the delivery by the Company to the
Registrar under the Indenture of Exchange Notes to be registered in the same
aggregate principal amount as the aggregate principal amount of Initial Notes
tendered by the Holders thereof pursuant to the Exchange Offer.

<PAGE>

      controlling person: As defined in Section 8(a) hereof.

      Effectiveness Deadline: As defined in Sections 3(a) and 4(a) hereof.

      Exchange Act: The Securities Exchange Act of 1934, as amended, and the
rules and regulations of the Commission promulgated thereunder.

      Exchange Notes: The Company's 8-3/4% Senior Notes due 2014 to be issued
pursuant to the Indenture: (i) in the Exchange Offer or (ii) as contemplated by
Section 4 hereof.

      Exchange Offer: The exchange and issuance by the Company of a principal
amount of Exchange Notes (which shall be registered pursuant to the Exchange
Offer Registration Statement) equal to the outstanding principal amount of
Initial Notes that are tendered by such Holders in connection with such exchange
and issuance.

      Exchange Offer Registration Statement: The Registration Statement relating
to the Exchange Offer, including the related Prospectus.

      Filing Deadline: As defined in Sections 3(a) and 4(a) hereof.

      Guarantors: The Guarantors defined in the preamble hereto and any Person
that becomes a guarantor of Notes after the date hereof pursuant to the terms of
the Indenture.

      Holders: As defined in Section 2 hereof.

      Indemnified Holder: As defined in Section 8(a) hereof.

      indemnified party: As defined in Section 8(c) hereof.

      indemnifying party: As defined in Section 8(c) hereof.

      Notes: Initial Notes and Exchange Notes (including guarantees thereof by
the Guarantors).

      Person: An individual, partnership, limited liability company,
corporation, trust, unincorporated organization, or a government or agency or
political subdivision thereof.

      Prospectus: The prospectus included in a Registration Statement at the
time such Registration Statement is declared effective, as amended or
supplemented by any prospectus supplement and by all other amendments thereto,
including post-effective amendments, and all material incorporated by reference
into such Prospectus.

      Recommencement Date: As defined in Section 6(d) hereof.

      Registration Default: As defined in Section 5 hereof.

      Registration Statement: Any registration statement of the Company and the
Guarantors relating to (a) an offering of any Exchange Notes (including
guarantees thereof by the Guarantors) pursuant to an Exchange Offer or (b) the
registration for resale of Transfer Restricted Securities pursuant to the Shelf
Registration Statement, in each case, (i) that is filed

                                       2
<PAGE>

pursuant to the provisions of this Agreement and (ii) including the Prospectus
included therein, all amendments and supplements thereto (including
post-effective amendments) and all exhibits and material incorporated by
reference therein.

      Regulation S: Regulation S promulgated under the Act.

      Rule 144: Rule 144 promulgated under the Act.

      Shelf Registration Statement: As defined in Section 4 hereof.

      Special Interest: As defined in Section 5 hereof.

      Suspension Notice: As defined in Section 6(d) hereof.

      TIA: The Trust Indenture Act of 1939 (15 U.S.C. Section 77aaa-77bbbb) as
in effect on the date of the Indenture.

      Transfer Restricted Securities: Each Initial Note, until the earliest to
occur of (a) the date on which such Initial Note has been exchanged by a Person
other than a Broker-Dealer for a Exchange Note in the Exchange Offer and
entitled to be resold to the public by the Holder thereof without complying with
the prospectus delivery requirements of the Act, (b) following the exchange by a
Broker-Dealer in the Exchange Offer of an Initial Note for an Exchange Note, the
date on which such Exchange Note is sold to a purchaser who receives from such
Broker-Dealer on or prior to the date of such sale a copy of the Prospectus
contained in the Exchange Offer Registration Statement, (c) the date on which
such Initial Note has been effectively registered under the Act and disposed of
in accordance with a Shelf Registration Statement (and the purchasers thereof
have been issued Exchange Notes), and (d) the date on which such Initial Note is
distributed to the public pursuant to Rule 144 (and the purchasers thereof have
been issued Exchange Notes).

SECTION 2. HOLDERS

      A Person is deemed to be a holder of Transfer Restricted Securities (each,
a "Holder") whenever such Person owns Transfer Restricted Securities.

SECTION 3. REGISTERED EXCHANGE OFFER

      (a)   Unless the Exchange Offer shall not be permitted by applicable
federal law or policy of the Commission (after the procedures set forth in
Section 6(a)(i) below have been complied with), the Company shall, and shall
cause the Guarantors to (i) file the Exchange Offer Registration Statement with
the Commission no later than 90 days after the Closing Date (such 90th day being
the "Filing Deadline"), (ii) use all commercially reasonable efforts to cause
such Exchange Offer Registration Statement to become effective no later than 180
days after the Closing Date (such 180th day being the "Effectiveness Deadline"),
(iii) in connection with the foregoing, (A) file all pre-effective amendments to
such Exchange Offer Registration Statement as may be necessary in order to cause
it to become effective, (B) file, if applicable, a post-effective amendment to
such Exchange Offer Registration Statement pursuant to Rule 430A under the Act
and (C) cause all necessary filings, if any, in connection with the registration
and qualification of the Exchange Notes to be made under the Blue Sky laws of
such jurisdictions as are necessary to

                                       3
<PAGE>

permit Consummation of the Exchange Offer, and (iv) upon the effectiveness of
such Exchange Offer Registration Statement, use all commercially reasonable
efforts to commence and Consummate the Exchange Offer. The Exchange Offer shall
be on the appropriate form permitting (x) registration of the Exchange Notes to
be offered in exchange for Initial Notes that are Transfer Restricted Securities
and (y) resales of Exchange Notes by any Broker-Dealer that tendered into the
Exchange Offer for Initial Notes that such Broker-Dealer acquired for its own
account as a result of market-making activities or other trading activities
(other than Initial Notes acquired directly from the Company or any of its
Affiliates) as contemplated by Section 3(c) below.

      (b)   The Company shall use, and shall cause the Guarantors to use, all
commercially reasonable efforts to cause the Exchange Offer Registration
Statement to be effective continuously, and shall keep the Exchange Offer open
for a period of not less than the minimum period required under applicable
federal and state securities laws to Consummate the Exchange Offer; provided,
however, that in no event shall such period be less than 20 Business Days. The
Company shall cause, and shall cause the Guarantors to cause, the Exchange Offer
to comply with all applicable federal and state securities laws. No securities
other than the Exchange Notes and the guarantees thereof shall be included in
the Exchange Offer Registration Statement. The Company shall use, and shall
cause the Guarantors to use, all commercially reasonable efforts to cause the
Exchange Offer to be Consummated on or prior to 30 Business Days after the
Exchange Offer Registration Statement has become effective, or longer, if
required by the federal securities laws.

      (c)   The Company and the Guarantors shall include a "Plan of
Distribution" section in the Prospectus contained in the Exchange Offer
Registration Statement and indicate therein that any Broker-Dealer who holds
Transfer Restricted Securities that were acquired for the account of such
Broker-Dealer as a result of market-making activities or other trading
activities (other than Initial Notes acquired directly from the Company or any
Affiliate of the Company) may exchange such Transfer Restricted Securities
pursuant to the Exchange Offer. Such "Plan of Distribution" section shall also
contain all other information with respect to such sales by such Broker-Dealers
that the Commission may require in order to permit such sales pursuant thereto,
but such "Plan of Distribution" shall not name any such Broker-Dealer or
disclose the amount of Transfer Restricted Securities held by any such
Broker-Dealer, except to the extent required by the Commission as a result of a
change in policy, rules or regulations after the date of this Agreement.

      Because such Broker-Dealer may be deemed to be an "underwriter" within the
meaning of the Act and must, therefore, deliver a prospectus meeting the
requirements of the Act in connection with its initial sale of any Exchange
Notes received by such Broker-Dealer in the Exchange Offer, the Company and the
Guarantors shall permit the use of the Prospectus contained in the Exchange
Offer Registration Statement by such Broker-Dealer to satisfy such prospectus
delivery requirement. To the extent necessary to ensure that the Exchange Offer
Registration Statement is available for sales of Exchange Notes by
Broker-Dealers, the Company agree to use, and to cause the Guarantors to use,
all commercially reasonable efforts to keep the Exchange Offer Registration
Statement continuously effective, supplemented and amended as required by the
provisions of Sections 6(a) and (c) hereof and in conformity with the
requirements of this Agreement, the Act and the policies, rules and regulations
of the Commission as announced from time to time, for a period of 180 days from
the date on which the Exchange Offer is Consummated, or such shorter period as
will terminate when all Transfer Restricted Securities covered by such
Registration Statement have been sold pursuant thereto. The Company shall
provide sufficient copies of the

                                       4
<PAGE>

latest version of such Prospectus to such Broker-Dealers, promptly upon request,
and in no event later than one day after such request, at any time during such
period.

SECTION 4. SHELF REGISTRATION

      (a)   Shelf Registration. If (i) the Exchange Offer is not Consummated by
the deadline specified therefor in Section 3(b) hereof, (ii) the Company and the
Guarantors are not permitted to conduct or Consummate the Exchange Offer because
the Exchange Offer is not permitted by applicable law or policy of the
Commission (after the Company and the Guarantors have complied with the
procedures set forth in Section 6(a)(i) below) or (iii) any Holder notifies the
Company in writing prior to the 20th Business Day following the Consummation of
the Exchange Offer that (A) upon advice of counsel such Holder was prohibited by
law or Commission policy from participating in the Exchange Offer, or (B) such
Holder may not resell the Exchange Notes acquired by it in the Exchange Offer to
the public without delivering a prospectus, and the Prospectus contained in the
Exchange Offer Registration Statement is not appropriate or available for such
resales by such Holder, or (C) such Holder is a Broker-Dealer and holds Initial
Notes acquired directly from the Company or any Affiliates of the Company, then
the Company shall use, and shall cause the Guarantors to use:

   (x)   all commercially reasonable efforts, on or prior to 30 days after
the earlier of (i) the deadline date specified in clause (a)(i) above, (ii) the
date on which the Company determines that the Exchange Offer Registration
Statement will not be or cannot be, as the case may be, filed as a result of
clause (a)(ii) above and (iii) the date on which the Company receives the notice
specified in clause (a)(iii) above (30 days after such earlier date, the "Filing
Deadline"), to file a shelf registration statement pursuant to Rule 415 under
the Act (which may be an amendment to the Exchange Offer Registration Statement
(the "Shelf Registration Statement")), relating to all Transfer Restricted
Securities of Holders that have provided the information required pursuant to
Section 4(b) hereof, and

   (y)   all commercially reasonable efforts to cause such Shelf Registration
Statement to become effective on or prior to 60 days after the Filing Deadline
for the Shelf Registration Statement (such 60th day the "Effectiveness
Deadline").

      If, after the Company and the Guarantors have filed an Exchange Offer
Registration Statement that satisfies the requirements of Section 3(a) above,
the Company and the Guarantors are required to file and make effective a Shelf
Registration Statement solely because the Exchange Offer is not permitted under
applicable federal law or policy of the Commission (i.e., Section 4(a)(ii)
above), then the filing of the Exchange Offer Registration Statement shall be
deemed to satisfy the requirements of clause (x) above; provided that, in such
event, the Company and the Guarantors shall remain obligated to meet the
Effectiveness Deadline set forth in clause (y) above.

      The Company shall use, and shall cause the Guarantors to use, all
commercially reasonable efforts to keep any Shelf Registration Statement
required by this Section 4(a) continuously effective, supplemented and amended
as required by and subject to the provisions of Sections 6(b) and (c) hereof to
the extent necessary to ensure that the Shelf Registration Statement (i) is
available for sales of Transfer Restricted Securities by the Holders thereof
entitled to the benefit of this Section 4(a) and (ii) conforms with the
requirements of this Agreement, the Act and the policies, rules and regulations
of the Commission as announced from time to time, for a period of at least two
years (as extended pursuant to Sections 6(c)(i) and (d) hereof) following the
Closing Date, or

                                       5
<PAGE>

such shorter period as will terminate when all Transfer Restricted Securities
covered by such Shelf Registration Statement have been sold pursuant thereto.

      (b)   Provision by Holders of Certain Information in Connection with the
Shelf Registration Statement. No Holder may include any of its Transfer
Restricted Securities in any Shelf Registration Statement pursuant to this
Agreement unless and until such Holder furnishes to the Company in writing,
within 20 days after receipt of a request therefor, the information specified in
Item 507 or 508 of Regulation S-K, as applicable, of the Act for use in
connection with any Shelf Registration Statement or Prospectus or preliminary
prospectus included therein. No Holder shall be entitled to Special Interest
pursuant to Section 5 hereof unless and until such Holder shall have provided
all such information (it being understood that Special Interest shall not accrue
for the benefit of any Holder until such Holder provides such information). Each
selling Holder agrees to promptly furnish to the Company additional information
required to be disclosed in order to make the information previously furnished
to the Company by such Holder not materially misleading.

SECTION 5. SPECIAL INTEREST

      If (i) any Registration Statement required by this Agreement is not filed
with the Commission on or prior to the applicable Filing Deadline, (ii) any such
Registration Statement has not been declared effective by the Commission on or
prior to the applicable Effectiveness Deadline, (iii) the Exchange Offer has not
been Consummated on or prior to 30 Business Days after the Effectiveness
Deadline with respect to the Exchange Offer Registration Statement or (iv)
subject to Section 6(c)(i) hereof, any Registration Statement required by this
Agreement is filed and declared effective but thereafter ceases to be effective
or fails to be usable for its intended purpose without being succeeded
immediately by a post-effective amendment to such Registration Statement that
cures such failure and that is itself declared effective immediately (each such
event referred to in clauses (i) through (iv), a "Registration Default"), then,
subject to Section 4(b) hereof, the Company and the Guarantors hereby jointly
and severally agree to pay to each Holder affected thereby special interest
("Special Interest"), with respect to the first 90-day period immediately
following the occurrence of the first Registration Default, in an amount equal
to 0.25% per annum on the outstanding principal amount of Transfer Restricted
Securities held by such Holder. The amount of Special Interest described in the
preceding sentence shall increase by an additional 0.25% per annum on the
outstanding principal amount of Transfer Restricted Securities with respect to
each subsequent 90-day period until all Registration Defaults have been cured,
up to a maximum amount of Special Interest for all Registration Defaults of
1.00% per annum on the outstanding principal amount of Notes constituting
Transfer Restricted Securities; provided that the Company and the Guarantors
shall in no event be required to pay Special Interest for more than one
Registration Default at any given time. Notwithstanding anything to the contrary
set forth herein, (1) upon filing of the Exchange Offer Registration Statement
(and/or, if applicable, the Shelf Registration Statement), in the case of clause
(i) above, (2) upon the effectiveness of the Exchange Offer Registration
Statement (and/or, if applicable, the Shelf Registration Statement), in the case
of clause (ii) above, (3) upon Consummation of the Exchange Offer, in the case
of clause (iii) above, or (4) upon the filing of a post-effective amendment to
the Registration Statement or an additional Registration Statement that causes
the Exchange Offer Registration Statement (and/or, if applicable, the Shelf
Registration Statement) to again be declared effective or made usable in the
case of clause (iv) above, the Special Interest payable with respect

                                       6
<PAGE>

to the Transfer Restricted Securities as a result of such clause (i), (ii),
(iii) or (iv), as applicable, shall cease.

      All accrued Special Interest shall be paid to the Holders entitled
thereto, in the manner provided for the payment of interest in the Indenture, on
each Interest Payment Date, as more fully set forth in the Indenture and the
Notes. All obligations of the Company and the Guarantors set forth in the
preceding paragraph that are outstanding with respect to any Transfer Restricted
Security at the time such security ceases to be a Transfer Restricted Security
shall survive until such time as all such obligations with respect to such
security shall have been satisfied in full.

SECTION 6. REGISTRATION PROCEDURES

      (a)   Exchange Offer Registration Statement. In connection with the
Exchange Offer, the Company shall, and shall cause the Guarantors to, (x) comply
with all applicable provisions of Section 6(c) below, (y) use all commercially
reasonable efforts to effect such exchange and to permit the resale of Exchange
Notes by any Broker-Dealer that tendered in the Exchange Offer Initial Notes
that such Broker-Dealer acquired for its own account as a result of its
market-making activities or other trading activities (other than Initial Notes
acquired directly from the Company or any Affiliates of the Company) being sold
in accordance with the intended method or methods of distribution thereof, and
(z) comply with all of the following provisions:

            (i)   If, following the date hereof there has been announced a
      change in Commission policy with respect to exchange offers such as the
      Exchange Offer, that in the reasonable opinion of counsel to the Company
      raises a substantial question as to whether the Exchange Offer is
      permitted by applicable federal law, the Company and the Guarantors hereby
      agree to seek a no-action letter or other favorable decision from the
      Commission allowing the Company and the Guarantors to Consummate an
      Exchange Offer for such Transfer Restricted Securities. The Company and
      the Guarantors hereby agree to pursue the issuance of such a decision to
      the Commission staff level. In connection with the foregoing, the Company
      and the Guarantors hereby agree to take all such other actions as may be
      requested by the Commission or otherwise required in connection with the
      issuance of such decision, including without limitation (A) participating
      in telephonic conferences with the Commission, (B) delivering to the
      Commission staff an analysis prepared by counsel to the Company setting
      forth the legal bases, if any, upon which such counsel has concluded that
      such an Exchange Offer should be permitted and (C) diligently pursuing a
      resolution (which need not be favorable) by the Commission staff.

            (ii)  As a condition to its participation in the Exchange Offer,
      each Holder (including, without limitation, any Holder who is a
      Broker-Dealer) shall furnish, upon the request of the Company, prior to
      the Consummation of the Exchange Offer, a written representation to the
      Company and the Guarantors (which may be contained in the letter of
      transmittal contemplated by the Exchange Offer Registration Statement) to
      the effect that (A) it is not an Affiliate of the Company, (B) it is not
      engaged in, and does not intend to engage in, and has no arrangement or
      understanding with any Person to participate in, a distribution of the
      Exchange Notes to be issued in the Exchange Offer and (C) it is acquiring
      the Exchange Notes in its ordinary course of business. Each Holder using
      the Exchange Offer to participate in a distribution of the Exchange Notes
      hereby acknowledges and agrees that, if the resales are of Exchange Notes
      obtained by such Holder in exchange

                                       7
<PAGE>

      for Initial Notes acquired directly from the Company or an Affiliate
      thereof, it (1) could not, under Commission policy as in effect on the
      date of this Agreement, rely on the position of the Commission enunciated
      in Morgan Stanley and Co., Inc. (available June 5, 1991) and Exxon Capital
      Holdings Corporation (available May 13, 1988), as interpreted in the
      Commission's letter to Shearman & Sterling dated July 2, 1993, and similar
      no-action letters (including, if applicable, any no-action letter obtained
      pursuant to clause (i) above), and (2) must comply with the registration
      and prospectus delivery requirements of the Act in connection with a
      secondary resale transaction and that such a secondary resale transaction
      must be covered by an effective registration statement containing the
      selling security holder information required by Item 507 or 508, as
      applicable, of Regulation S-K.

            (iii) Prior to effectiveness of the Exchange Offer Registration
      Statement, the Company and the Guarantors shall provide a supplemental
      letter to the Commission (A) stating that the Company and the Guarantors
      are registering the Exchange Offer in reliance on the position of the
      Commission enunciated in Exxon Capital Holdings Corporation (available May
      13, 1988), Morgan Stanley and Co., Inc. (available June 5, 1991) as
      interpreted in the Commission's letter to Shearman & Sterling dated July
      2, 1993, and, if applicable, any no-action letter obtained pursuant to
      clause (i) above, (B) including a representation that neither the Company
      nor any Guarantor has entered into any arrangement or understanding with
      any Person to distribute the Exchange Notes to be received in the Exchange
      Offer and that, to the best of the Company's and each Guarantor's
      information and belief, each Holder participating in the Exchange Offer is
      acquiring the Exchange Notes in its ordinary course of business and has no
      arrangement or understanding with any Person to participate in the
      distribution of the Exchange Notes received in the Exchange Offer and (C)
      any other undertaking or representation required by the Commission as set
      forth in any no-action letter obtained pursuant to clause (i) above, if
      applicable.

      (b)   Shelf Registration Statement. In connection with the Shelf
Registration Statement, the Company shall comply, and shall cause the Guarantors
to comply, with all the provisions of Section 6(c) below, and the Company shall
use, and shall cause the Guarantors to use, all commercially reasonable efforts
to effect such registration to permit the sale of the Transfer Restricted
Securities being sold in accordance with the intended method or methods of
distribution thereof (as indicated in the information furnished to the Company
pursuant to Section 4(b) hereof), and pursuant thereto the Company and the
Guarantors will prepare and file with the Commission a Registration Statement
relating to the registration on any appropriate form under the Act, which form
shall be available for the sale of the Transfer Restricted Securities in
accordance with the intended method or methods of distribution thereof within
the time periods and otherwise in accordance with the provisions hereof.

      (c)   General Provisions. In connection with any Registration Statement
and any related Prospectus required by this Agreement, the Company shall, and
shall cause the Guarantors to:

            (i)   use all commercially reasonable efforts to keep such
      Registration Statement continuously effective and provide all requisite
      financial statements for the period specified in Section 3 or 4 hereof, as
      applicable. Upon the occurrence of any event that would cause any such
      Registration Statement or the Prospectus contained therein (A) to contain
      an untrue statement of a material fact or omit to state any material fact
      necessary to make the

                                       8
<PAGE>

      statements therein not misleading or (B) not to be effective or usable for
      resale of Transfer Restricted Securities during the period required by
      this Agreement, the Company and the Guarantors shall file promptly an
      appropriate amendment to such Registration Statement curing such defect,
      and, if Commission review is required, use all commercially reasonable
      efforts to cause such amendment to be declared effective as soon as
      practicable. Notwithstanding the foregoing, if the Board of Directors of
      the Company determines in good faith that it is in the best interests of
      the Company and the Guarantors not to disclose the existence of, or facts
      surrounding, any proposed or pending material corporate transaction or
      other material development involving the Company or the Guarantors, the
      Company and the Guarantors may allow the Shelf Registration Statement to
      fail to be effective or the Prospectus contained therein to be unusable as
      a result of such nondisclosure for up to ninety (90) days in any year
      during the two-year period of effectiveness required by Section 4 hereof;

            (ii)  prepare and file with the Commission such amendments and
      post-effective amendments to the applicable Registration Statement as may
      be necessary to keep such Registration Statement effective for the
      applicable period set forth in Section 3 or 4 hereof, as the case may be;
      cause the Prospectus to be supplemented by any required Prospectus
      supplement, and as so supplemented to be filed pursuant to Rule 424 under
      the Act, and to comply fully with Rules 424, 430A and 462, as applicable,
      under the Act in a timely manner; and comply with the provisions of the
      Act with respect to the disposition of all securities covered by such
      Registration Statement during the applicable period in accordance with the
      intended method or methods of distribution by the sellers thereof set
      forth in such Registration Statement or supplement to the Prospectus;

            (iii) with respect to a Shelf Registration Statement, advise the
      selling Holders promptly and, if requested by such Person, confirm such
      advice in writing, (A) when the Prospectus or any Prospectus supplement or
      post-effective amendment has been filed, and, with respect to any
      applicable Registration Statement or any post-effective amendment thereto,
      when the same has become effective, (B) of any request by the Commission
      for amendments to the Registration Statement or amendments or supplements
      to the Prospectus or for additional information relating thereto, (C) of
      the issuance by the Commission of any stop order suspending the
      effectiveness of the Registration Statement under the Act or of the
      suspension by any state securities commission of the qualification of the
      Transfer Restricted Securities for offering or sale in any jurisdiction,
      or the initiation of any proceeding for any of the preceding purposes, and
      (D) of the existence of any fact or the happening of any event that makes
      any statement of a material fact made in the Registration Statement, the
      Prospectus, any amendment or supplement thereto or any document
      incorporated by reference therein untrue, or that requires the making of
      any additions to or changes in the Registration Statement in order to make
      the statements therein not misleading, or that requires the making of any
      additions to or changes in the Prospectus in order to make the statements
      therein, in the light of the circumstances under which they were made, not
      misleading. If at any time the Commission issues any stop order suspending
      the effectiveness of the Registration Statement, or any state securities
      commission or other regulatory authority issues an order suspending the
      qualification or exemption from qualification of the Transfer Restricted
      Securities under state securities or Blue Sky laws, the Company and the
      Guarantors shall use all commercially reasonable efforts to obtain the
      withdrawal or lifting of such order at the earliest possible time;

                                       9
<PAGE>

            (iv)  subject to Section 6(c)(i) hereof, if any fact or event
      contemplated by Section 6(c)(iii)(D) above exists or has occurred, prepare
      a supplement or post-effective amendment to the Registration Statement or
      related Prospectus or any document incorporated therein by reference or
      file any other required document so that, as thereafter delivered to the
      purchasers of Transfer Restricted Securities, the Prospectus will not
      contain an untrue statement of a material fact or omit to state any
      material fact necessary to make the statements therein, in the light of
      the circumstances under which they were made, not misleading;

            (v)   with respect to a Shelf Registration Statement, furnish to the
      Initial Purchasers and each selling Holder named in any Registration
      Statement or Prospectus in connection with such sale, if any, before
      filing with the Commission, copies of any Registration Statement or any
      Prospectus included therein or any amendments or supplements to any such
      Registration Statement or Prospectus (including all documents incorporated
      by reference after the initial filing of such Registration Statement),
      which documents will be subject to the review and comment of such Holders
      in connection with such sale, if any, for a period of at least five
      Business Days, and the Company will not file any such Registration
      Statement or Prospectus or any amendment or supplement to any such
      Registration Statement or Prospectus (including all such documents
      incorporated by reference) to which the selling Holders of the Transfer
      Restricted Securities covered by such Registration Statement in connection
      with such sale, if any, have reasonably objected within five Business Days
      after the receipt thereof. A selling Holder shall be deemed to have
      reasonably objected to such filing if such Registration Statement,
      amendment, Prospectus or supplement, as applicable, as proposed to be
      filed, contains an untrue statement of a material fact or omits to state
      any material fact necessary to make the statements therein not misleading
      or fails to comply with the applicable requirements of the Act;

            (vi)  with respect to a Shelf Registration Statement, use
      commercially reasonable efforts, promptly prior to the filing of any
      document that is to be incorporated by reference into a Registration
      Statement or Prospectus, to provide copies of such document to the selling
      Holders in connection with such sale, if any, make the Company's and the
      Guarantors' representatives available for discussion of such document and
      other customary due diligence matters, and include such information in
      such document prior to the filing thereof as such selling Holders may
      reasonably request;

            (vii) with respect to a Shelf Registration Statement, make available
      at reasonable times for inspection by the selling Holders participating in
      any disposition pursuant to such Registration Statement and any attorney
      or accountant retained by such selling Holders, all financial and other
      records, pertinent corporate documents of the Company and the Guarantors
      and cause the Company's and the Guarantors' officers, directors and
      employees to supply all information reasonably requested by any such
      selling Holder, attorney or accountant in connection with such
      Registration Statement or any post-effective amendment thereto subsequent
      to the filing thereof and prior to its effectiveness;

            (viii) with respect to a Shelf Registration Statement, if requested
      by any selling Holders in connection with such sale, if any, promptly
      include in any Registration Statement or Prospectus, pursuant to a
      supplement or post-effective amendment if

                                       10
<PAGE>

      necessary, such information as such selling Holders may reasonably request
      to have included therein, including, without limitation, information
      relating to the "Plan of Distribution" of the Transfer Restricted
      Securities; and make all required filings of such Prospectus supplement or
      post-effective amendment as soon as practicable after the Company is
      notified of the matters to be included in such Prospectus supplement or
      post-effective amendment;

            (ix)  with respect to a Shelf Registration Statement, furnish to
      each selling Holder in connection with such sale, if any, without charge,
      one copy of the Registration Statement, as first filed with the
      Commission, and of each amendment thereto, including all documents
      incorporated by reference therein and all exhibits (including exhibits
      incorporated therein by reference);

            (x)   with respect to a Shelf Registration Statement, deliver to
      each selling Holder, without charge, as many copies of the Prospectus
      (including each preliminary prospectus) and any amendment or supplement
      thereto as such Persons reasonably may request; the Company and the
      Guarantors hereby consent to the use (in accordance with law) of the
      Prospectus and any amendment or supplement thereto by each of the selling
      Holders in connection with the offering and the sale of the Transfer
      Restricted Securities covered by the Prospectus or any amendment or
      supplement thereto;

            (xi)  with respect to a Shelf Registration Statement, upon the
      request of any selling Holder, enter into such agreements (including
      underwriting agreements containing customary terms) and make such
      representations and warranties and take all such other actions in
      connection therewith in order to expedite or facilitate the disposition of
      the Transfer Restricted Securities pursuant to any applicable Registration
      Statement contemplated by this Agreement as may be reasonably requested by
      any Holder in connection with any sale or resale pursuant to any
      applicable Registration Statement. In such connection, the Company shall,
      and shall cause the Guarantors to:

            (A)   upon request of any selling Holder, furnish (or in the case of
         paragraphs (2) and (3), use all commercially reasonable efforts to
         cause to be furnished) to each selling Holder, upon the effectiveness
         of the Shelf Registration Statement:

                  (1)   a certificate, dated such date, signed on behalf of the
            Company and each Guarantor by (x) the President or any Vice
            President and (y) a principal financial or accounting officer of the
            Company and such Guarantor, confirming, as of the date thereof, the
            matters, to the extent applicable, set forth in paragraphs (a) and
            (b) of Section 7 of the Purchase Agreement and such other similar
            matters as the selling Holders may reasonably request;

                  (2)   an opinion, dated the date of effectiveness of the Shelf
            Registration Statement of counsel for the Company and the Guarantors
            covering customary matters and such other matters as the selling
            Holders may reasonably request, and in any event including a
            statement (or a separate letter) with respect to the Registration
            Statement and the related Prospectus to the effect set forth in a
            customary negative assurance letter; and

                                       11
<PAGE>

                  (3)   a customary comfort letter, dated the date of
            effectiveness of the Shelf Registration Statement from the Company's
            independent accountants, in the customary form and covering matters
            of the type customarily covered in comfort letters to underwriters
            in connection with underwritten offerings, and affirming the matters
            set forth in the comfort letters delivered pursuant to Section 7(g)
            of the Purchase Agreement;

            (B)   set forth in full or incorporated by reference in the
         underwriting agreement, if any, the indemnification provisions and
         procedures of Section 8 hereof with respect to all parties to be
         indemnified pursuant to said Section; and

            (C)   deliver such other documents and certificates as may be
         reasonably requested by the selling Holders to evidence compliance with
         clause (A) above and with any customary conditions contained in any
         agreement entered into by the Company and the Guarantors pursuant to
         this clause (xi);

            If at any time the representations and warranties of the Company and
      each of the Guarantors set forth in the certificate contemplated in clause
      (A)(1) above cease to be true and correct, the Company shall so advise the
      Initial Purchasers and the underwriters, if any, and each selling Holder
      promptly and, if requested by such Persons, shall confirm such advice in
      writing;

            (xii) prior to any public offering of Transfer Restricted
      Securities, cooperate with the selling Holders and their counsel in
      connection with the registration and qualification of the Transfer
      Restricted Securities under the securities or Blue Sky laws of such
      jurisdictions as the selling Holders may request and do any and all other
      acts or things necessary or advisable to enable the disposition in such
      jurisdictions of the Transfer Restricted Securities covered by the
      applicable Registration Statement; provided, however, that neither the
      Company nor any Guarantor shall be required to register or qualify as a
      foreign corporation where it is not now so qualified or to take any action
      that would subject it to the service of process in suits or to taxation,
      other than as to matters and transactions relating to the Registration
      Statement, in any jurisdiction where it is not now so subject;

            (xiii) issue, upon the request of any Holder of Initial Notes
      covered by any Shelf Registration Statement contemplated by this
      Agreement, Exchange Notes having an aggregate principal amount equal to
      the aggregate principal amount of Initial Notes surrendered to the Company
      by such Holder in exchange therefor or being sold by such Holder, such
      Exchange Notes to be registered in the name of such Holder or in the name
      of the purchaser(s) of such Exchange Notes; in return, the Initial Notes
      held by such Holder shall be surrendered to the Company for cancellation;

            (xiv) in connection with any sale of Transfer Restricted Securities
      that will result in such securities no longer being Transfer Restricted
      Securities, cooperate with the Holders to facilitate the timely
      preparation and delivery of certificates representing Transfer Restricted
      Securities to be sold and not bearing any restrictive legends; and to
      register such Transfer Restricted Securities in such denominations and
      such names as the selling Holders may request at least two Business Days
      prior to such sale of Transfer Restricted Securities;

                                       12
<PAGE>

            (xv)  provide a CUSIP number for all Transfer Restricted Securities
      not later than the effective date of a Registration Statement covering
      such Transfer Restricted Securities and provide the Trustee under the
      Indenture with printed certificates for the Transfer Restricted Securities
      which are in a form eligible for deposit with The Depository Trust
      Company;

            (xvi) otherwise use all commercially reasonable efforts to comply
      with all applicable rules and regulations of the Commission, and make
      generally available to its security holders with regard to any applicable
      Registration Statement, as soon as practicable, a consolidated earnings
      statement meeting the requirements of Rule 158 under the Act (which need
      not be audited) covering a twelve-month period beginning after the
      effective date of the Registration Statement (as such term is defined in
      paragraph (c) of Rule 158 under the Act);

            (xvii) cause the Indenture to be qualified under the TIA not later
      than the effective date of the first Registration Statement required by
      this Agreement and, in connection therewith, cooperate with the Trustee
      and the Holders to effect such changes to the Indenture as may be required
      for such Indenture to be so qualified in accordance with the terms of the
      TIA; and execute and use all commercially reasonable efforts to cause the
      Trustee to execute, all documents that may be required to effect such
      changes and all other forms and documents required to be filed with the
      Commission to enable such Indenture to be so qualified in a timely manner;
      and

            (xviii) provide promptly to each Holder, upon request, each document
      filed with the Commission pursuant to the requirements of Section 13 or
      Section 15(d) of the Exchange Act.

      (d)   Restrictions on Holders. Each Holder agrees by acquisition of a
Transfer Restricted Security that, upon receipt of the notice referred to in
Section 6(c)(iii)(C) hereof or any notice from the Company of the existence of
any fact of the kind described in Section 6(c)(i) or Section 6(c)(iii)(D) hereof
(in each case, a "Suspension Notice"), such Holder will forthwith discontinue
disposition of Transfer Restricted Securities pursuant to the applicable
Registration Statement until (i) such Holder has received copies of the
supplemented or amended Prospectus contemplated by Section 6(c)(iv) hereof, or
(ii) such Holder is advised in writing by the Company that the use of the
Prospectus may be resumed, and has received copies of any additional or
supplemental filings that are incorporated by reference in the Prospectus (in
each case, the "Recommencement Date"). Each Holder receiving a Suspension Notice
hereby agrees that it will either (i) destroy any Prospectuses, other than
permanent file copies, then in such Holder's possession which have been replaced
by the Company with more recently dated Prospectuses or (ii) deliver to the
Company (at the Company's expense) all copies, other than permanent file copies,
then in such Holder's possession of the Prospectus covering such Transfer
Restricted Securities that was current at the time of receipt of the Suspension
Notice. The time period regarding the effectiveness of such Registration
Statement set forth in Section 3 or 4 hereof, as applicable, shall be extended
by a number of days equal to the number of days in the period from and including
the date of delivery of the Suspension Notice to the Recommencement Date.

                                       13
<PAGE>

SECTION 7. REGISTRATION EXPENSES

      (a)   All expenses incident to the Company's and the Guarantors'
performance of or compliance with this Agreement will be borne by the Company
and the Guarantors, regardless of whether a Registration Statement becomes
effective, including without limitation: (i) all registration and filing fees
and expenses; (ii) all fees and expenses of compliance with federal securities
and state Blue Sky or securities laws; (iii) all expenses of printing (including
printing certificates for the Exchange Notes to be issued in the Exchange Offer
and printing of Prospectuses), messenger and delivery services and telephone;
(iv) all fees and disbursements of counsel for the Company and the Guarantors;
(v) all application and filing fees in connection with listing the Exchange
Notes on a national securities exchange or automated quotation system pursuant
to the requirements hereof; and (vi) all fees and disbursements of independent
certified public accountants of the Company and the Guarantors (including the
expenses of any special audit and comfort letters required by or incident to
such performance).

      The Company will, in any event, bear its and the Guarantors' internal
expenses (including, without limitation, all salaries and expenses of its
officers and employees performing legal or accounting duties), the expenses of
any annual audit and the fees and expenses of any Person, including special
experts, retained by the Company or the Guarantors.

      (b)   In connection with any Registration Statement required by this
Agreement (including, without limitation, the Exchange Offer Registration
Statement and the Shelf Registration Statement), the Company and the Guarantors
will reimburse the Initial Purchasers and the Holders of Transfer Restricted
Securities being tendered in the Exchange Offer and/or resold pursuant to the
"Plan of Distribution" contained in the Exchange Offer Registration Statement or
registered pursuant to the Shelf Registration Statement, as applicable, for the
reasonable fees and disbursements of not more than one counsel (not to exceed
$25,000), who shall be Latham & Watkins LLP, unless another firm shall be chosen
by the Holders of a majority in principal amount of the Transfer Restricted
Securities for whose benefit such Registration Statement is being prepared.

SECTION 8. INDEMNIFICATION

      (a)   The Company and the Guarantors, jointly and severally, agree to
indemnify and hold harmless (i) each Holder and (ii) each Person, if any, who
controls (within the meaning of Section 15 of the Act or Section 20 of the
Exchange Act) any Holder (any of the Persons referred to in this clause (ii)
being hereinafter referred to as a "controlling person") and (iii) the
respective officers, directors, partners and employees of any Holder or any
controlling person (any Person referred to in clause (i), (ii) or (iii) may
hereinafter be referred to as an "Indemnified Holder"), from and against any and
all losses, claims, damages, liabilities or judgments, (including without
limitation, any legal or other expenses reasonably incurred in connection with
investigating or defending any matter, including any action that could give rise
to any such losses, claims, damages, liabilities or judgments) caused by any
untrue statement or alleged untrue statement of a material fact contained in any
Registration Statement, preliminary prospectus or Prospectus (or any amendment
or supplement thereto) provided by the Company to any Holder or any prospective
purchaser of Exchange Notes or registered Initial Notes, or caused by any
omission or alleged omission to state therein a material fact required to be
stated therein or necessary to make the statements therein not misleading,
except insofar as such losses, claims, damages, liabilities or

                                       14
<PAGE>

judgments are caused by an untrue statement or omission or alleged untrue
statement or omission that is based upon information relating to any of the
Holders furnished in writing to the Company by any of the Holders.

      (b)   Each Holder agrees, severally and not jointly, to indemnify and hold
harmless the Company and the Guarantors, and their respective directors and
officers, and each Person, if any, who controls (within the meaning of Section
15 of the Act or Section 20 of the Exchange Act) the Company or the Guarantors
to the same extent as the foregoing indemnity from the Company and the
Guarantors to each of the Indemnified Holders, but only with reference to
information relating to such Indemnified Holder furnished in writing to the
Company by such Indemnified Holder expressly for use in any Registration
Statement. In no event shall any Indemnified Holder be liable or responsible for
any amount in excess of the amount by which the total amount received by such
Indemnified Holder with respect to its sale of Transfer Restricted Securities
pursuant to a Registration Statement exceeds the amount paid by such Indemnified
Holder for such Transfer Restricted Securities.

      (c)   In case any action shall be commenced involving any Person in
respect of which indemnity may be sought pursuant to Section 8(a) or 8(b) hereof
(the "indemnified party"), the indemnified party shall promptly notify the
Person against whom such indemnity may be sought (the "indemnifying party") in
writing and the indemnifying party shall assume the defense of such action,
including the employment of counsel reasonably satisfactory to the indemnified
party and the payment of all fees and expenses of such counsel, as incurred
(except that in the case of any action in respect of which indemnity may be
sought pursuant to both Sections 8(a) and 8(b) hereof, an Indemnified Holder
shall not be required to assume the defense of such action pursuant to this
Section 8(c), but may employ separate counsel and participate in the defense
thereof, but the fees and expenses of such counsel, except as provided below,
shall be at the expense of the Indemnified Holder). Any indemnified party shall
have the right to employ separate counsel in any such action and participate in
the defense thereof, but the fees and expenses of such counsel shall be at the
expense of the indemnified party unless (i) the employment of such counsel has
been specifically authorized in writing by the indemnifying party, (ii) the
indemnifying party has failed to assume the defense of such action or employ
counsel reasonably satisfactory to the indemnified party or (iii) the named
parties to any such action (including any impleaded parties) include both the
indemnified party and the indemnifying party, and the indemnified party has been
advised by such counsel that there may be one or more legal defenses available
to it that are different from or additional to those available to the
indemnifying party (in which case the indemnifying party shall not have the
right to assume the defense of such action on behalf of the indemnified party).
In any such case, the indemnifying party shall not, in connection with any one
action or separate but substantially similar or related actions in the same
jurisdiction arising out of the same general allegations or circumstances, be
liable for the fees and expenses of more than one separate firm of attorneys (in
addition to any local counsel) for all indemnified parties and all such fees and
expenses shall be reimbursed as they are incurred. Such firm shall be designated
in writing by a majority of the Indemnified Holders, in the case of the parties
indemnified pursuant to Section 8(a) hereof, and by the Company, in the case of
parties indemnified pursuant to Section 8(b) hereof. The indemnifying party
shall indemnify and hold harmless the indemnified party from and against any and
all losses, claims, damages, liabilities and judgments by reason of any
settlement of any action effected with its written consent. No indemnifying
party shall, without the prior written consent of the indemnified party, effect
any settlement or compromise of, or consent to the entry of judgment with
respect to, any pending or threatened action in respect of which the indemnified

                                       15
<PAGE>

party is or could have been a party and indemnity or contribution may be or
could have been sought hereunder by the indemnified party, unless such
settlement, compromise or judgment (i) includes an unconditional release of the
indemnified party from all liability on claims that are or could have been the
subject matter of such action and (ii) does not include a statement as to or an
admission of fault, culpability or a failure to act, by or on behalf of the
indemnified party.

      (d)   To the extent that the indemnification provided for in this Section
8 is unavailable to an indemnified party in respect of any losses, claims,
damages, liabilities or judgments referred to therein, then each indemnifying
party, in lieu of indemnifying such indemnified party, shall contribute to the
amount paid or payable by such indemnified party as a result of such losses,
claims, damages, liabilities or judgments (i) in such proportion as is
appropriate to reflect the relative benefits received by the Company and the
Guarantors, on the one hand, and the Holders, on the other hand, from their sale
of Transfer Restricted Securities or (ii) if the allocation provided by clause
8(d)(i) above is not permitted by applicable law, in such proportion as is
appropriate to reflect not only the relative benefits referred to in clause
8(d)(i) above but also the relative fault of the Company and the Guarantors, on
the one hand, and of the Indemnified Holder, on the other hand, in connection
with the statements or omissions which resulted in such losses, claims, damages,
liabilities or judgments, as well as any other relevant equitable
considerations. The relative fault of the Company and the Guarantors, on the one
hand, and of the Indemnified Holder, on the other hand, shall be determined by
reference to, among other things, whether the untrue or alleged untrue statement
of a material fact or the omission or alleged omission to state a material fact
relates to information supplied by the Company or such Guarantor, on the one
hand, or by the Indemnified Holder, on the other hand, and the parties' relative
intent, knowledge, access to information and opportunity to correct or prevent
such statement or omission. The amount paid or payable by a party as a result of
the losses, claims, damages, liabilities and judgments referred to above shall
be deemed to include any legal or other fees or expenses reasonably incurred by
such party in connection with investigating or defending any action or claim.

      The Company, the Guarantors and each Holder agree that it would not be
just and equitable if contribution pursuant to this Section 8(d) were determined
by pro rata allocation (even if the Holders were treated as one entity for such
purpose) or by any other method of allocation that does not take account of the
equitable considerations referred to in the immediately preceding paragraph. The
amount paid or payable by an indemnified party as a result of the losses,
claims, damages, liabilities or judgments referred to in the immediately
preceding paragraph shall be deemed to include, subject to the limitations set
forth above, any legal or other expenses reasonably incurred by such indemnified
party in connection with investigating or defending any matter, including any
action that could have given rise to such losses, claims, damages, liabilities
or judgments. Notwithstanding the provisions of this Section 8, no Holder or its
related Indemnified Holders shall be required to contribute, in the aggregate,
any amount in excess of the amount by which the total received by such Holder
with respect to the sale of Transfer Restricted Securities pursuant to a
Registration Statement exceeds the sum of (A) the amount paid by such Holder for
such Transfer Restricted Securities plus (B) the amount of any damages that such
Holder has otherwise been required to pay by reason of such untrue or alleged
untrue statement or omission or alleged omission. No Person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Act) shall be
entitled to contribution from any Person who was not guilty of such fraudulent
misrepresentation. The Holders' obligations to contribute pursuant to this
Section 8(d) are several in proportion to the respective principal amount of
Transfer Restricted Securities held by each Holder hereunder and not joint.

                                       16
<PAGE>

      The agreements contained in this Section 8 shall survive the sale of the
Transfer Restricted Securities pursuant to a Registration Statement and shall
remain in full force and effect regardless of any termination or cancellation of
this Agreement.

SECTION 9. RULE 144A AND RULE 144

      The Company and each Guarantor hereby agrees with each Holder, for so long
as any Transfer Restricted Securities remain outstanding and during any period
in which the Company or such Guarantor is not subject to Section 13 or 15(d) of
the Exchange Act, to make available, upon request of any Holder, to any Holder
or beneficial owner of Transfer Restricted Securities in connection with any
sale thereof and any prospective purchaser of such Transfer Restricted
Securities designated by such Holder or beneficial owner, the information
required by Rule 144A(d)(4) under the Act in order to permit resales of such
Transfer Restricted Securities pursuant to Rule 144A under the Act.

SECTION 10. MISCELLANEOUS

      (a)   Remedies. The Company and the Guarantors acknowledge and agree that
any failure by the Company and/or the Guarantors to comply with their respective
obligations under Sections 3 and 4 hereof may result in material irreparable
injury to the Initial Purchasers or the Holders for which there is no adequate
remedy at law, that it will not be possible to measure damages for such injuries
precisely and that, in the event of any such failure, the Initial Purchasers or
any Holder may obtain such relief as may be required to specifically enforce the
Company's and the Guarantors' obligations under Sections 3 and 4 hereof. The
Company and the Guarantors further agree to waive the defense in any action for
specific performance that a remedy at law would be adequate.

      (b)   No Inconsistent Agreements. Neither the Company nor any Guarantor
will, on or after the date of this Agreement, enter into any agreement with
respect to its securities that is inconsistent with the rights granted to the
Holders in this Agreement or otherwise conflicts with the provisions hereof.
Neither the Company nor any Guarantor has previously entered into any agreement
granting any registration rights with respect to its securities to any Person.
The rights granted to the Holders hereunder do not in any way conflict with and
are not inconsistent with the rights granted to the holders of the Company's and
the Guarantors' securities under any agreement in effect on the date hereof.

      (c)   Adjustments Affecting the Notes. Neither the Company nor any of the
Guarantors shall take any action, or permit any change to occur, with respect to
the Notes that would materially and adversely affect the ability of the Holders
to Consummate any Exchange Offer.

      (d)   Amendments and Waivers. The provisions of this Agreement may not be
amended, modified or supplemented, and waivers or consents to or departures from
the provisions hereof may not be given unless (i) in the case of Section 5
hereof and this Section 10(d)(i), the Company has obtained the written consent
of Holders of all outstanding Transfer Restricted Securities and (ii) in the
case of all other provisions hereof, the Company has obtained the written
consent of Holders of a majority of the outstanding principal amount of Transfer
Restricted Securities (excluding Transfer Restricted Securities held by the
Company or its Affiliates). Notwithstanding the foregoing, a waiver or consent
to departure from the provisions hereof that relates exclusively to the rights
of Holders whose securities are being tendered pursuant to the Exchange Offer,
and

                                       17
<PAGE>

that does not affect directly or indirectly the rights of other Holders whose
securities are not being tendered pursuant to such Exchange Offer, may be given
by the Holders of a majority of the outstanding principal amount of Transfer
Restricted Securities subject to such Exchange Offer.

      (e)   Additional Guarantors. IASIS Healthcare LLC shall cause any of its
Subsidiaries (as defined in the Indenture) that becomes, prior to the
Consummation of the Exchange Offer, a Guarantor in accordance with the terms and
provisions of the Indenture to become a party to this Agreement as a Guarantor.

      (f)   Third Party Beneficiary. The Holders shall be third party
beneficiaries to the agreements made hereunder between the Company and the
Guarantors, on the one hand, and the Initial Purchasers, on the other hand, and
shall have the right to enforce such agreements directly to the extent they may
deem such enforcement necessary or advisable to protect its rights or the rights
of Holders hereunder.

      (g)   Notices. All notices and other communications provided for or
permitted hereunder shall be made in writing by hand-delivery, first-class mail
(registered or certified, return receipt requested), facsimile, or air courier
guaranteeing overnight delivery:

            (i)   if to a Holder, at the address set forth on the records of the
      Registrar under the Indenture, with a copy to the Registrar under the
      Indenture; and

            (ii)  if to the Company or the Guarantors:

                  IASIS Healthcare LLC
                  117 Seaboard Lane
                  Building E
                  Franklin, Tennessee 37067
                  Facsimile No.: (615) 846-3006
                  Attention:  General Counsel

                  With a copy to:

                  Cleary, Gottlieb, Steen & Hamilton
                  One Liberty Plaza
                  New York, New York  10006
                  Facsimile No.: (212) 225-3999
                  Attention:  Michael L. Ryan

      All such notices and communications shall be deemed to have been duly
given: at the time delivered by hand, if personally delivered; five Business
Days after being deposited in the mail, postage prepaid, if mailed; when receipt
acknowledged, if sent by facsimile; and on the next Business Day, if timely
delivered to an air courier guaranteeing overnight delivery.

      Copies of all such notices, demands or other communications shall be
concurrently delivered by the Person giving the same to the Trustee at the
address specified in the Indenture.

                                       18
<PAGE>

      Upon the date of filing of the Exchange Offer or a Shelf Registration
Statement, as the case may be, notice shall be delivered to the Initial
Purchasers in the form attached hereto as Exhibit A.

      (h)   Successors and Assigns. This Agreement shall inure to the benefit of
and be binding upon the successors and assigns of each of the parties, including
without limitation and without the need for an express assignment, subsequent
Holders; provided that nothing herein shall be deemed to permit any assignment,
transfer or other disposition of Transfer Restricted Securities in violation of
the terms hereof or of the Purchase Agreement or the Indenture. If any
transferee of any Holder shall acquire Transfer Restricted Securities in any
manner, whether by operation of law or otherwise, such Transfer Restricted
Securities shall be held subject to all of the terms of this Agreement, and by
taking and holding such Transfer Restricted Securities such Person shall be
conclusively deemed to have agreed to be bound by and to perform all of the
terms and provisions of this Agreement, including the restrictions on resale set
forth in this Agreement and, if applicable, the Purchase Agreement, and such
Person shall be entitled to receive the benefits hereof.

      (i)   Counterparts. This Agreement may be executed in any number of
counterparts and by the parties hereto in separate counterparts, each of which
when so executed shall be deemed to be an original and all of which taken
together shall constitute one and the same agreement.

      (j)   Headings. The headings in this Agreement are for convenience of
reference only and shall not limit or otherwise affect the meaning hereof.

      (k)   Governing Law. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN
ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK, WITHOUT REGARD TO THE
CONFLICT OF LAWS PROVISIONS THEREOF. EACH OF THE PARTIES HERETO AGREES TO SUBMIT
TO THE JURISDICTION OF THE COURTS OF THE STATE OF NEW YORK IN ANY ACTION OR
PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT.

      (l)   Severability. In the event that any one or more of the provisions
contained herein, or the application thereof in any circumstance, is held
invalid, illegal or unenforceable, the validity, legality and enforceability of
any such provision in every other respect and of the remaining provisions
contained herein shall not be affected or impaired thereby.

      (m)   Entire Agreement. This Agreement is intended by the parties as a
final expression of their agreement and intended to be a complete and exclusive
statement of the agreement and understanding of the parties hereto in respect of
the subject matter contained herein. There are no restrictions, promises,
warranties or undertakings, other than those set forth or referred to herein
with respect to the registration rights granted with respect to the Transfer
Restricted Securities. This Agreement supersedes all prior agreements and
understandings between the parties with respect to such subject matter.

                            [Signature pages follow]

                                       19
<PAGE>

      IN WITNESS WHEREOF, the parties have executed this Agreement as of the
date first written above.

                                  IASIS HEALTHCARE LLC

                                           By: /s/ W. Carl Whitmer
                                               -------------------------------
                                               Name: W. Carl Whitmer
                                               Title: Chief Financial Officer

                                  IASIS CAPITAL CORPORATION

                                           By: /s/ W. Carl Whitmer
                                               -------------------------------
                                               Name: W. Carl Whitmer
                                               Title: Chief Financial Officer

                                   MEMORIAL HOSPITAL OF TAMPA, LP
                                   MESA GENERAL HOSPITAL, LP
                                   PALMS OF PASADENA HOSPITAL, LP
                                   SOUTHWEST GENERAL HOSPITAL, LP
                                   ST. LUKE'S BEHAVIORAL HOSPITAL, LP
                                   ST. LUKE'S MEDICAL CENTER, LP
                                   TEMPE ST. LUKE'S HOSPITAL, LP
                                   TOWN & COUNTRY HOSPITAL, LP

                                       By: IASIS Healthcare Holdings, Inc.,
                                           as General Partner

                                           By: /s/ Frank A. Coyle
                                               -------------------------------
                                               Name: Frank A. Coyle
                                               Title: Secretary

<PAGE>

                                 SEABOARD DEVELOPMENT LLC

                                         By: /s/ Frank A. Coyle
                                             --------------------------------
                                             Name: Frank A. Coyle
                                             Title: Secretary

                                 ARIZONA DIAGNOSTIC & SURGICAL CENTER, INC.
                                 BROOKWOOD DIAGNOSTIC CENTER OF TAMPA, INC.
                                 IASIS PHYSICIAN SERVICES, INC.
                                 CLINICARE OF TEXAS, INC.
                                 IASIS HOME INFUSION AND MEDICAL EQUIPMENT, INC.
                                 IASIS TRANSCO, INC.
                                 MCS/AZ, INC.
                                 PALMS OF PASADENA HOMECARE, INC.
                                 TAMPA BAY STAFFING SOLUTIONS, INC.
                                 BAPTIST JOINT VENTURE HOLDINGS, INC.
                                 BEAUMONT HOSPITAL HOLDINGS, INC.
                                 BILTMORE SURGERY CENTER HOLDINGS, INC.
                                 CLINICARE OF UTAH, INC.
                                 DAVIS HOSPITAL HOLDINGS, INC.
                                 DAVIS SURGICAL CENTER HOLDINGS, INC.
                                 FIRST CHOICE PHYSICIANS NETWORK HOLDINGS, INC.
                                 IASIS FINANCE, INC.
                                 IASIS HEALTHCARE HOLDINGS, INC.
                                 IASIS HOSPITAL NURSE STAFFING COMPANY
                                 IASIS MANAGEMENT COMPANY
                                 JORDAN VALLEY HOSPITAL HOLDINGS, INC.
                                 METRO AMBULATORY SURGERY CENTER, INC.
                                 PIONEER VALLEY HEALTH PLAN, INC.
                                 PIONEER VALLEY HOSPITAL, INC.
                                 ROCKY MOUNTAIN MEDICAL CENTER, INC.
                                 SALT LAKE REGIONAL MEDICAL CENTER, INC.
                                 SOUTHRIDGE PLAZA HOLDINGS, INC.
                                 SSJ ST. PETERSBURG HOLDINGS, INC.
                                 BILTMORE SURGERY CENTER, INC.
                                 NORTH VISTA HOSPITAL, INC.

                                         By: /s/ Frank A. Coyle
                                             --------------------------------
                                             Name: Frank A. Coyle
                                             Title: Secretary

<PAGE>

BANC OF AMERICA SECURITIES LLC

By: /s/ James D. Jeffries
    -------------------------------
    Name: James D. Jeffries
    Title: Managing Director

CITIGROUP GLOBAL MARKETS INC.

By: /s/ Richard Landgarten
    -------------------------------
    Name: Richard Landgarten
    Title: Managing Director,
           US Co-Head of Health Care
           Investment Banking

GOLDMAN, SACHS & CO.

By: /s/ Goldman, Sachs & Co.
    -------------------------------
    Name:
    Title:

LEHMAN BROTHERS INC.

By: /s/ Stephen Mehos
    -------------------------------
    Name: Stephen Mehos
    Title: Managing Director

MERRILL LYNCH, PIERCE, FENNER & SMITH
                   INCORPORATED

By: /s/ M. Toby King
    ------------------------------
    Name: M. Toby King
    Title: Vice President

WACHOVIA CAPITAL MARKETS, LLC

By: /s/ Lewis S. Morris, III
    ------------------------------
    Name: Lewis S. Morris, III
    Title: Vice President

<PAGE>

                                    EXHIBIT A

                   NOTICE OF FILING OF REGISTRATION STATEMENT

To:   Banc of America Securities LLC
      Citigroup Global Markets Inc.
      Goldman, Sachs & Co.
      Lehman Brothers Inc.
      Merrill Lynch, Pierce, Fenner & Smith Incorporated
      Wachovia Capital Markets, LLC
          c/o Banc of America Securities LLC
          9 West 57th Street, 2M Floor
          New York, New York  10019
          Attn: High Yield Syndicate Department
          Fax:  (212) 583-8324

From: IASIS Healthcare LLC
      117 Seaboard Lane
      Building E
      Franklin, Tennessee  37067
      Fax:  (615) 846-3006

Re: 8-3/4% Senior Subordinated Notes due 2014

Date: ________________, 2004

      For your information only (NO ACTION REQUIRED):

            Today, ________________, 2004, we filed with the Securities and
Exchange Commission [an Exchange Registration Statement] [a Shelf Registration
Statement] relating to the 8-3/4% Senior Subordinated Notes due 2014 of IASIS
Healthcare LLC and IASIS Capital Corporation. We currently expect this
registration statement to be declared effective within __ business days of the
date hereof.<PAGE>
                                                                     EXHIBIT 4.5

                                 [Face of Note]
--------------------------------------------------------------------------------

                                                         CUSIP/CINS ____________

                    8-3/4% Senior Subordinated Note due 2014

No. ___                                                            $____________

                              IASIS Healthcare LLC

                            IASIS Capital Corporation

promises to pay to ____________________ or registered assigns,

the principal sum of ___________________________________________ DOLLARS on
June 15, 2014.

Interest Payment Dates:  June 15 and December 15

Record Dates:  June 1 and December 1

Dated:  _______________, 200_

                                       IASIS Healthcare LLC

                                       By:
                                           -----------------------------------
                                           Name:
                                           Title:

                                       IASIS Capital Corporation

                                       By:
                                           -----------------------------------
                                           Name:
                                           Title:

This is one of the Notes referred to
in the within-mentioned Indenture:

THE BANK OF NEW YORK TRUST COMPANY, N.A.,
  as Trustee

By:
    -------------------------------------
            Authorized Signatory

--------------------------------------------------------------------------------

                                       1

<PAGE>

                                 [Back of Note]
                    8-3/4% Senior Subordinated Notes due 2014

THIS GLOBAL NOTE IS HELD BY THE DEPOSITARY (AS DEFINED IN THE INDENTURE
GOVERNING THIS NOTE) OR ITS NOMINEE IN CUSTODY FOR THE BENEFIT OF THE BENEFICIAL
OWNERS HEREOF, AND IS NOT TRANSFERABLE TO ANY PERSON UNDER ANY CIRCUMSTANCES
EXCEPT THAT (1) THE TRUSTEE MAY MAKE SUCH NOTATIONS HEREON AS MAY BE REQUIRED
PURSUANT TO SECTION 2.01 AND SECTION 2.06 OF THE INDENTURE, (2) THIS GLOBAL NOTE
MAY BE EXCHANGED IN WHOLE BUT NOT IN PART PURSUANT TO SECTION 2.06(a) OF THE
INDENTURE, (3) THIS GLOBAL NOTE MAY BE DELIVERED TO THE TRUSTEE FOR CANCELLATION
PURSUANT TO SECTION 2.11 OF THE INDENTURE AND (4) THIS GLOBAL NOTE MAY BE
TRANSFERRED TO A SUCCESSOR DEPOSITARY WITH THE PRIOR WRITTEN CONSENT OF THE
ISSUERS.

UNLESS AND UNTIL IT IS EXCHANGED IN WHOLE OR IN PART FOR NOTES IN DEFINITIVE
FORM, THIS NOTE MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITARY TO A
NOMINEE OF THE DEPOSITARY OR BY A NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR
ANOTHER NOMINEE OF THE DEPOSITARY OR BY THE DEPOSITARY OR ANY SUCH NOMINEE TO A
SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH SUCCESSOR DEPOSITARY. UNLESS THIS
CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST
COMPANY (55 WATER STREET, NEW YORK, NEW YORK) ("DTC"), TO THE COMPANY OR ITS
AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE
ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR SUCH OTHER NAME AS MAY BE
REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO
CEDE & CO. OR SUCH OTHER ENTITY AS MAY BE REQUESTED BY AN AUTHORIZED
REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR
OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER
HEREOF, CEDE & CO., HAS AN INTEREST HEREIN.

         Capitalized terms used herein have the meanings assigned to them in the
Indenture referred to below unless otherwise indicated.

                  (1) INTEREST. IASIS Healthcare LLC, a Delaware limited
         liability company (the "Company"), and IASIS Capital Corporation, a
         Delaware corporation ("IASIS Capital" and together with the Company,
         the "Issuers"), promise to pay interest on the principal amount of this
         Note at 8-3/4% per annum from ____________, 20__ until maturity. The
         Issuers shall pay interest semi-annually in arrears on June 15 and
         December 15 of each year, or if any such day is not a Business Day, on
         the next succeeding Business Day (each, an "Interest Payment Date").
         Interest on the Notes shall accrue from the most recent date to which
         interest has been paid or, if no interest has been paid, from the date
         of issuance; provided that if there is no existing Default in the
         payment of interest, and if this Note is authenticated between a record
         date referred to on the face hereof and the next succeeding Interest
         Payment Date, interest shall accrue from such next succeeding

                                       2
<PAGE>

         Interest Payment Date; provided further that the first Interest Payment
         Date shall be ____________, 20__. The Issuers shall pay interest
         (including post-petition interest in any proceeding under any
         Bankruptcy Law) on overdue principal and premium, if any, from time to
         time on demand at a rate that is 1% per annum in excess of the rate
         then in effect; it shall pay interest (including post-petition interest
         in any proceeding under any Bankruptcy Law) on overdue installments of
         interest (without regard to any applicable grace periods) from time to
         time on demand at the same rate to the extent lawful. Interest shall be
         computed on the basis of a 360-day year of twelve 30-day months.

                  (2) METHOD OF PAYMENT. The Issuers shall pay interest on the
         Notes (except defaulted interest) to the Persons who are registered
         Holders at the close of business on the June 1 or December 1 next
         preceding the Interest Payment Date, even if such Notes are canceled
         after such record date and on or before such Interest Payment Date,
         except as provided in Section 2.12 of the Indenture with respect to
         defaulted interest. The Notes shall be payable as to principal,
         interest and premium at the office or agency of the Paying Agent within
         the City and State of New York, or, at the option of the Issuers,
         payment of interest may be made by check mailed to the Holders at their
         addresses set forth in the register of Holders; provided that payment
         by wire transfer of immediately available funds shall be required with
         respect to principal of and interest and premium, if any, on, all
         Global Notes and all other Notes the Holders of which shall have
         provided wire transfer instructions to the Issuers or the Paying Agent.
         Such payment shall be in such coin or currency of the United States of
         America as at the time of payment is legal tender for payment of public
         and private debts.

                  (3) PAYING AGENT AND REGISTRAR. Initially, The Bank of New
         York Trust Company, N.A., the Trustee under the Indenture, shall act as
         Paying Agent and Registrar. The Issuers may change any Paying Agent or
         Registrar without notice to any Holder. The Company or any of its
         Subsidiaries may act in any such capacity.

                  (4) INDENTURE. The Issuers issued the Notes under an Indenture
         dated as of June 22, 2004 (the "Indenture"), among the Issuers, the
         Guarantors and the Trustee. The terms of the Notes include those stated
         in the Indenture and those made part of the Indenture by reference to
         the TIA (15 U.S. Code ss.ss. 77aaa-77bbbb). The Notes are subject to
         all such terms, and Holders are referred to the Indenture and such Act
         for a statement of such terms. To the extent any provision of this Note
         conflicts with the express provisions of the Indenture, the provisions
         of the Indenture shall govern and be controlling. The Notes are general
         unsecured obligations of the Issuers. Subject to the conditions set
         forth in the Indenture, the Issuers may issue Additional Notes.

                  (5) OPTIONAL REDEMPTION.

                  (a) Except as set forth in subparagraph (b) of this Paragraph
         5, the Issuers shall not have the option to redeem the Notes prior to
         June 15, 2009. On or after June 15, 2009, the Issuers may redeem all or
         part of the Notes upon not less than 30 nor more than 60 days' notice,
         at the redemption prices (expressed as percentages of principal amount)
         set forth below plus accrued and unpaid interest thereon to the
         applicable redemption date, if redeemed during the twelve-month period
         beginning on June 15 of the years

                                       3
<PAGE>

         indicated below, subject to the rights of Holders on the relevant
         record date to receive interest on the relevant interest payment date:

<TABLE>
<CAPTION>
         Year                                                        Percentage
         ----                                                        ----------
<S>                                                                  <C>
         2009..................................................       104.375%
         2010..................................................       102.917%
         2011..................................................       101.458%
         2012 and thereafter...................................       100.000%
</TABLE>

                  (b) Notwithstanding the provisions of subparagraph (a) of this
         Paragraph 5, at any time prior to June 15, 2007, the Issuers may, on
         any one or more occasions, redeem up to 35% of the aggregate principal
         amount of Notes issued under the Indenture at a redemption price of
         108.750% of the principal amount thereof, plus accrued and unpaid
         interest to the redemption date with the net cash proceeds of one or
         more Equity Offerings by the Issuers or a contribution to the common
         equity capital of the Company from the net proceeds of one or more
         Equity Offerings by a direct or indirect parent of the Company (in each
         case, other than Excluded Contributions and the net proceeds of a sale
         of Designated Preferred Stock); provided that (i) at least 65% in
         aggregate principal amount of the Notes originally issued under the
         Indenture (excluding Notes held by the Company and its Subsidiaries)
         remains outstanding immediately after the occurrence of such
         redemption; and (ii) the redemption occurs within 90 days of the date
         of the closing of such Equity Offering or equity contribution.

                  (6) MANDATORY REDEMPTION. The Issuers shall not be required to
         make mandatory redemption payments with respect to the Notes.

                  (7) REPURCHASE AT THE OPTION OF HOLDER.

                  (a) If there is a Change of Control, each Holder shall have
         the right to require the Issuers to make an offer (a "Change of Control
         Offer") to repurchase all or any part (equal to $1,000 or an integral
         multiple of $1,000) of that Holder's Notes at a purchase price equal to
         101% of the aggregate principal amount thereof plus accrued and unpaid
         interest on the Notes repurchased, if any, to the date of purchase,
         subject to the rights of the Holders on the relevant record date to
         receive interest due on the relevant Interest Payment Date (the "Change
         of Control Payment"). Within 30 days following any Change of Control,
         the Issuers shall mail a notice to each Holder setting forth the
         procedures governing the Change of Control Offer as required by the
         Indenture.

                  (b) If the Company or a Restricted Subsidiary of the Company
         consummates any Asset Sales, within 10 Business Days of each date on
         which the aggregate amount of Excess Proceeds exceeds $15.0 million,
         the Company shall commence an Asset Sale Offer to all Holders and if
         the Company elects (or is required by the terms of such other pari
         passu indebtedness) all holders of other Indebtedness that is pari
         passu with the Notes pursuant to Section 3.09 of the Indenture to
         purchase the maximum principal amount of Notes and other pari passu
         Indebtedness that may be purchased out of the Excess Proceeds at an
         offer price in cash in an amount equal to 100% of the principal amount
         thereof plus accrued and unpaid interest to the Purchase Date in
         accordance with

                                       4
<PAGE>

         the procedures set forth in the Indenture. To the extent that the
         aggregate amount of Notes and other pari passu Indebtedness tendered
         pursuant to an Asset Sale Offer is less than the Excess Proceeds, the
         Company (or such Restricted Subsidiary) may use the remaining Excess
         Proceeds for any purpose not otherwise prohibited by the Indenture. If
         the aggregate principal amount of Notes and other pari passu
         Indebtedness surrendered by holders thereof exceeds the amount of
         Excess Proceeds, the Trustee shall select the Notes and other pari
         passu Indebtedness to be purchased on a pro rata basis. Holders to whom
         an Asset Sale Offer is addressed shall receive an Asset Sale Offer from
         the Company prior to the related Purchase Date and may elect to have
         such Notes purchased by completing the form entitled "Option of Holder
         to Elect Purchase" attached to the Notes.

                  (8) NOTICE OF REDEMPTION. Notice of redemption shall be mailed
         at least 30 days but not more than 60 days before the redemption date
         to each Holder whose Notes are to be redeemed at its registered
         address, except that redemption notices may be mailed more than 60 days
         prior to a redemption date if the notice is issued in connection with a
         defeasance of the Notes or a satisfaction and discharge of the
         Indenture. Notes in denominations larger than $1,000 may be redeemed in
         part but only in whole multiples of $1,000, unless all of the Notes
         held by a Holder are to be redeemed. On and after the redemption date
         interest ceases to accrue on Notes or portions thereof called for
         redemption.

                  (9) DENOMINATIONS, TRANSFER, EXCHANGE. The Notes are in
         registered form without coupons in denominations of $1,000 and integral
         multiples of $1,000. The transfer of Notes may be registered and Notes
         may be exchanged as provided in the Indenture. The Registrar and the
         Trustee may require a Holder, among other things, to furnish
         appropriate endorsements and transfer documents and the Issuers may
         require a Holder to pay any taxes and fees required by law or permitted
         by the Indenture. The Issuers need not exchange or register the
         transfer of any Note or portion of a Note selected for redemption,
         except for the unredeemed portion of any Note being redeemed in part.
         Also, the Issuers need not exchange or register the transfer of any
         Notes for a period of 15 days before a selection of Notes to be
         redeemed or during the period between a record date and the
         corresponding Interest Payment Date.

                  (10) PERSONS DEEMED OWNERS. The registered Holder of a Note
         may be treated as its owner for all purposes.

                  (11) AMENDMENT, SUPPLEMENT AND WAIVER. Subject to certain
         exceptions, the Indenture, the Subsidiary Guarantees or the Notes may
         be amended or supplemented with the consent of the Holders of at least
         a majority in aggregate principal amount of the then outstanding Notes,
         including without limitation, consents obtained in connection with a
         purchase of, or tender offer or exchange offer for, Notes, and any
         existing Default or Event of Default or compliance with any provision
         of the Indenture, the Subsidiary Guarantees or the Notes may be waived
         with the consent of the Holders of a majority in aggregate principal
         amount of the then outstanding Notes, including without limitation,
         consents obtained in connection with a purchase of, or tender offer or
         exchange offer for, Notes. Without the consent of any Holder, the
         Indenture, the Subsidiary Guarantees or

                                       5
<PAGE>

         the Notes may be amended or supplemented (i) to cure any ambiguity,
         defect or inconsistency, (ii) to provide for uncertificated Notes in
         addition to or in place of certificated Notes, (iii) to provide for the
         assumption of the Company's or any Guarantor's obligations to Holders
         of the Notes in case of a merger or consolidation, (iv) to make any
         change that would provide any additional rights or benefits to the
         Holders or that does not adversely affect the legal rights under the
         Indenture of any such Holder, (v) to comply with the requirements of
         the SEC in order to effect or maintain the qualification of the
         Indenture under the TIA, (vi) to conform the text of the Indenture, the
         Subsidiary Guarantees or the Notes to any provision of the "Description
         of Notes" section of the Offering Memorandum to the extent that such
         provision in that "Description of Notes" was intended to be a verbatim
         recitation of a provision of the Indenture, the Subsidiary Guarantees
         or the Notes, (vii) to provide for the issuance of Additional Notes in
         accordance with the limitations set forth in the Indenture as of the
         Issue Date, (viii) to allow any Guarantor to execute a supplemental
         indenture and/or a Subsidiary Guarantee with respect to the Notes, or
         (ix) to issue the Exchange Notes. In addition, (a) any amendment to the
         provisions of Article 10 of the Indenture (including the definitions of
         "Senior Debt" and "Designated Senior Debt") that adversely affects the
         rights of any holder of Senior Debt of the Company then outstanding
         requires the consent of the holders of such Senior Debt (or any group
         or representative thereof authorized to give a consent), and (b) any
         amendment or waiver of the provisions of Article 10 of the Indenture
         that adversely affects the rights of the Holders requires the consent
         of the Holders of at least 66 2/3% in aggregate principal amount of
         Notes then outstanding.

                  (12) DEFAULTS AND REMEDIES. Events of Default include: (i)
         default for 30 days in the payment when due of interest on the Notes,
         whether or not prohibited by the subordination provisions of the
         Indenture; (ii) default in payment when due (at maturity, upon
         redemption or otherwise) of the principal of, or premium, if any, on
         the Notes whether or not prohibited by the subordination provisions of
         the Indenture; (iii) failure by the Company to comply with Section 5.01
         of the Indenture; (iv) failure by the Company or any of its Restricted
         Subsidiaries for 60 days after notice to the Company by the Trustee or
         the Holders of at least 25% in aggregate principal amount of Notes then
         outstanding voting as a single class to comply with any of the other
         agreements in the Indenture; (v) default under any mortgage, indenture
         or instrument under which there may be issued or by which there may be
         secured or evidenced any Indebtedness for money borrowed by the Company
         or any of its Significant Subsidiaries (or the payment of which is
         guaranteed by the Company or any of its Significant Subsidiaries),
         whether such Indebtedness or Guarantee now exists, or is created after
         the date of the Indenture, if that default: (a) is caused by a failure
         to pay principal at the final Stated Maturity of such Indebtedness (a
         "Payment Default") or (b) results in the acceleration of such
         Indebtedness prior to its express maturity, and, in each case, the
         principal amount of such Indebtedness, together with the principal
         amount of any other such Indebtedness under which there has been a
         Payment Default or the maturity of which has been so accelerated,
         aggregates $15.0 million or more; (vi) certain final judgments and
         decrees for the payment of money that remain undischarged for a period
         of 60 days after such judgment has become final and nonappealable;
         (vii) except as permitted by the Indenture, any Subsidiary Guarantee of
         any Significant Subsidiary is declared to be unenforceable or invalid
         by any final and nonappealable judgment or decree or ceases for any
         reason to be

                                       6
<PAGE>

         in full force and effect, or any Guarantor, that is a Significant
         Subsidiary or any Person acting on behalf of any Guarantor that is a
         Significant Subsidiary denies or disaffirms its obligations in writing
         under its Subsidiary Guarantee and such Default continues for 10 days
         after receipt of the notice specified in the Indenture and (viii)
         certain events of bankruptcy or insolvency with respect to the Issuers
         or any of the Company's Restricted Subsidiaries that is a Significant
         Subsidiary. If any Event of Default occurs and is continuing, the
         Trustee or the Holders of at least 25% in aggregate principal amount of
         the then outstanding Notes may declare all the Notes to be due and
         payable; provided that so long as any Indebtedness permitted to be
         incurred pursuant to the Credit Facilities is outstanding, such
         acceleration will not be effective until the earlier of (1) the
         acceleration of such Indebtedness under the Credit Facilities or (2)
         five Business Days after receipt by the Company of written notice of
         such acceleration. Notwithstanding the foregoing, in the case of an
         Event of Default arising from certain events of bankruptcy or
         insolvency, all outstanding Notes shall become due and payable without
         further action or notice. Holders may not enforce the Indenture or the
         Notes except as provided in the Indenture. Subject to certain
         limitations, Holders of a majority in principal amount of the then
         outstanding Notes may direct the Trustee in its exercise of any trust
         or power. The Trustee may withhold from Holders notice of any
         continuing Default or Event of Default (except a Default or Event of
         Default relating to the payment of principal or interest) if it
         determines that withholding notice is in their interest. The Holders of
         a majority in aggregate principal amount of the Notes then outstanding
         by notice to the Trustee may on behalf of the Holders of all of the
         Notes waive any existing Default or Event of Default and its
         consequences under the Indenture except a continuing Default or Event
         of Default in the payment of the principal of, premium or interest on,
         the Notes (including in connection with an offer to purchase). The
         Company is required to deliver to the Trustee annually a statement
         regarding compliance with the Indenture, and the Company is required
         upon becoming aware of any Default or Event of Default, to deliver to
         the Trustee a statement specifying such Default or Event of Default.

                  (13) SUBORDINATION. All Obligations in respect of the Notes
         are subordinated to the prior payment in full in cash of all Senior
         Debt of the Issuers (whether outstanding on the Issue Date or created,
         incurred, assumed or guaranteed thereafter) on the terms provided in
         the Indenture.

                  (14) TRUSTEE DEALINGS WITH COMPANY. The Trustee, in its
         individual or any other capacity, may make loans to, accept deposits
         from, and perform services for the Company or its Affiliates, and may
         otherwise deal with the Company or its Affiliates, as if it were not
         the Trustee.

                  (15) NO RECOURSE AGAINST OTHERS. A director, officer,
         employee, incorporator, stockholder or member of the Issuers or any of
         the Guarantors, as such, shall not have any liability for any
         obligations of the Issuers or such Guarantor under the Notes, the
         Subsidiary Guarantees or the Indenture or for any claim based on, in
         respect of, or by reason of, such obligations or their creation. Each
         Holder by accepting a Note waives and releases all such liability. The
         waiver and release are part of the consideration for the issuance of
         the Notes.

                                       7
<PAGE>

                  (16) AUTHENTICATION. This Note shall not be valid until
         authenticated by the manual signature of the Trustee or an
         authenticating agent.

                  (17) ABBREVIATIONS. Customary abbreviations may be used in the
         name of a Holder or an assignee, such as: TEN COM (= tenants in
         common), TEN ENT (= tenants by the entireties), JT TEN (= joint tenants
         with right of survivorship and not as tenants in common), CUST
         (= Custodian), and U/G/M/A (= Uniform Gifts to Minors Act).

                  (18) CUSIP NUMBERS. Pursuant to a recommendation promulgated
         by the Committee on Uniform Security Identification Procedures, the
         Company has caused CUSIP numbers to be printed on the Notes and the
         Trustee may use CUSIP numbers in notices of redemption as a convenience
         to Holders. No representation is made as to the accuracy of such
         numbers either as printed on the Notes or as contained in any notice of
         redemption and reliance may be placed only on the other identification
         numbers placed thereon.

         The Company shall furnish to any Holder upon written request and
without charge a copy of the Indenture and/or the Registration Rights Agreement.
Requests may be made to:

                  IASIS Healthcare LLC
                  IASIS Capital Corporation
                  117 Seaboard Lane, Building E
                  Franklin, Tennessee 37067
                  Telecopier No.:  (615) 846-3006
                  Attention:  General Counsel

                                       8
<PAGE>
                                 ASSIGNMENT FORM

         To assign this Note, fill in the form below:

               (I) or (we) assign and transfer this Note to:

               -----------------------------------------------------------------
                         (Insert assignee's legal name)

               -----------------------------------------------------------------
                       (Insert assignee's soc. sec. or tax I.D. no.)

               -----------------------------------------------------------------

               -----------------------------------------------------------------

               -----------------------------------------------------------------

               -----------------------------------------------------------------
                      (Print or type assignee's name, address and zip code)

               and irrevocably appoint
                                       -----------------------------------------
               to transfer this Note on the books of the Company. The agent may
               substitute another to act for him.

Date:  _______________

                                       Your Signature:
                                                      --------------------------
                                       (Sign exactly as your name appears on the
                                                              face of this Note)

Signature Guarantee*:  _________________________

* Participant in a recognized Signature Guarantee Medallion Program (or other
signature guarantor acceptable to the Trustee).

                                       9
<PAGE>
                       OPTION OF HOLDER TO ELECT PURCHASE

         If you want to elect to have this Note purchased by the Company
pursuant to Section 4.10 or 4.15 of the Indenture, check the appropriate box
below:

                   [ ] Section 4.10       [ ] Section 4.15

         If you want to elect to have only part of the Note purchased by the
Company pursuant to Section 4.10 or Section 4.15 of the Indenture, state the
amount you elect to have purchased:

                               $---------------

Date: _______________

                                      Your Signature:
                                                     ---------------------------
                                       (Sign exactly as your name appears on the
                                                              face of this Note)

                                      Tax Identification No.:
                                                             -------------------

Signature Guarantee*:  _________________________

* Participant in a recognized Signature Guarantee Medallion Program (or other
signature guarantor acceptable to the Trustee).

                                       10

<PAGE>
             SCHEDULE OF EXCHANGES OF INTERESTS IN THE GLOBAL NOTE*

         The following exchanges of a part of this Global Note for an interest
in another Global Note or for a Definitive Note, or exchanges of a part of
another Global Note or Definitive Note for an interest in this Global Note, have
been made:

<TABLE>
<CAPTION>
                                                                           Principal Amount
                           Amount of decrease    Amount of increase in    of this Global Note       Signature of
                           in Principal Amount      Principal Amount        following such       authorized officer
                                   of                      of                  decrease            of Trustee or
    Date of Exchange        this Global Note        this Global Note         (or increase)            Custodian
    ----------------        ----------------        ----------------         -------------            ---------
<S>                        <C>                   <C>                      <C>                    <C>

</TABLE>

*  This schedule should be included only if the Note is issued in global form

                                       11

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00068-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00068-of-00352.parquet"}]]